Showing results (911-920 of 16,169) with videos related to

Sort By:
Pageof 1,617
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Antibacterial quaternary ammonium agents: Chemical diversity and biological mechanismWenjia Dan, Jixiang Gao, Xiaohui Qi, et al.
European Journal of Medicinal Chemistry|October 4, 2022
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against TrypanosomaValeria Napolitano, Piotr Mróz, Monika Marciniak, et al.
European Journal of Medicinal Chemistry|September 30, 2022
Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphataseMarco Robello, Hongchao Zheng, Mrinmoy Saha, et al.
European Journal of Medicinal Chemistry|September 26, 2022
Design, synthesis, and biological evaluation of low-toxic lappaconitine derivatives as potential analgesicsYuzhu Li, Yushan Shang, Xiaohuan Li, et al.
European Journal of Medicinal Chemistry|September 29, 2022
Triterpenoid pyrazines and pyridines - Synthesis, cytotoxicity, mechanism of action, preparation of prodrugsJiří Hodoň, Ivo Frydrych, Zdeňka Trhlíková, et al.
European Journal of Medicinal Chemistry|September 29, 2022
Identification and immunological evaluation of novel TLR2 agonists through structural optimization of DiprovocimXianyang Wang, Yujie Wang, Yueyue Zhu, et al.
European Journal of Medicinal Chemistry|October 9, 2022
The development of small-molecule inhibitors targeting HPK1Lixin Zhou, Tianyu Wang, Kuojun Zhang, et al.
European Journal of Medicinal Chemistry|October 9, 2022
Design, synthesis and structure-activity relationship of dihydrobenzoquinolines as novel inhibitors against influenza A virusHui Liao, Yinyan Li, Luqiang Yu, et al.
European Journal of Medicinal Chemistry|October 2, 2022
Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectivesPanpan Yang, Yumeng Zhu, Qinwen Zheng, et al.
Pageof 1,617